Q4 2024 Vireo Growth Inc Earnings Call Transcript
Key Points
- Vireo Growth Inc (VREOF) reported record revenue, gross margin, and operating income for the full year 2024, with total revenue increasing by 15.4% year-over-year to approximately $100 million.
- The company ended the year with a strong financial position, holding $91.6 million in cash following an oversubscribed $81 million private placement.
- Vireo Growth Inc (VREOF) is making strategic growth investments in Minnesota and New York, including the buildout of a new state-of-the-art indoor cultivation facility in Minnesota.
- The company is well-positioned for a transformational year in 2025, with pending merger transactions expected to generate significant value for stakeholders.
- Vireo Growth Inc (VREOF) achieved a record gross margin of 51.1% for the full year, driven by the commencement of adult-use sales in Maryland and the disposition of lower-margin operations in New Mexico.
- Net loss for the year increased to $28 million compared to $25.5 million in 2023, primarily due to increased other expenses and taxes.
- Fourth quarter net loss was $15.7 million, significantly higher than the $4.6 million loss in the same period of 2023, impacted by one-time transaction expenses and increased stock-based compensation.
- Revenue growth in New York was offset by declines from medical-only dispensaries, indicating challenges in that market.
- The company incurred $4.2 million in one-time transaction expenses related to pending merger transactions, impacting fourth-quarter operating income.
- Vireo Growth Inc (VREOF) faces uncertainties related to regulatory and shareholder approvals for its merger transactions, which could affect the anticipated timeline and outcomes.
Good morning and welcome to Vireo Growth Inc.'s fourth-quarter and full year 2024 results call.
The company would like to remind everyone that today's conference call may contain forward-looking statements within the meaning of US and Canadian securities laws. These statements are based on management's current expectation and involves risk and uncertainties that could differ materially from actual events in those described in such forward-looking statements. For more information or forward-looking statements, please refer to cautionary note regarding forward-looking statements in the company's earnings release.
I will now hand the call over to Chief Executive Officer, John Mazarakis. Please go ahead, sir.
Thank you. Good morning, everyone. I'll begin with a summary of our performance and recent business highlights, and then Tyson will provide some extra details on the financials and our balance sheet.
Our fourth quarter results reflected continued strength and fundamental
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
